Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
2025-01-08 Option Award |
2025-01-10 4:15 pm |
N/A N/A |
Lyra Therapeutics Inc. | LYRA | Cavalier Jason Chief Financial Officer |
420,000 | $0 | 520,000 (Direct) |
View |
2024-10-16 Option Award |
2024-10-18 4:05 pm |
N/A N/A |
Lyra Therapeutics Inc. | LYRA | Cavalier Jason Chief Financial Officer |
100,000 | $0 | 100,000 (Direct) |
View |
2024-01-30 Option Award |
2024-02-01 4:15 pm |
N/A 2034-01-29 |
Lyra Therapeutics Inc. | LYRA | Cavalier Jason Chief Financial Officer |
200,000 | $0 | 200,000 (Direct) |
View |
2023-01-31 Option Award |
2023-02-02 5:11 pm |
N/A 2033-01-30 |
Lyra Therapeutics Inc. | LYRA | Cavalier Jason Chief Financial Officer |
140,000 | $0 | 140,000 (Direct) |
View |
2022-02-12 Option Award |
2022-02-15 9:30 pm |
N/A 2032-02-11 |
Lyra Therapeutics Inc. | LYRA | Cavalier Jason Chief Financial Officer |
15,605 | $0 | 15,605 (Direct) |
View |
2021-09-13 Option Award |
2021-09-15 5:44 pm |
N/A 2031-09-12 |
Lyra Therapeutics Inc. | LYRA | Cavalier Jason Chief Financial Officer |
104,000 | $0 | 104,000 (Direct) |
View |